Ann: Return of Capital - MYX (updated), page-36

I really should ignore you, as for some reason you show aggression towards anyone that actually sticks to the published or recorded facts. Yet when you post there is a one sided/100% positive view which is difficult to explain based on the information available ?!?! Generally your approach is called ramping.

On this occasion I'II stick to this post - and these words:
"THE TRICK THEN IS TO CAPTURE THE SALES VIA A PROFITABLE CONDUIT, which they have set up with dermatology products."

You need to refer to the new CEO update (30.11.22) in which is was evident that something smells bad with the Derm revenue. Had they been over stated? Has product stocking been banked as revenue which was returned? Us investors are still awaiting the reasons for Derm falling in a hole and being a significant reason for the MYX share price heading south when the MCS sale showed a significant extraordinary profit.

The year to date update showed the arse falling out of the only other segment (aside from MCS) that was operating well.



On Nextstellis. You make it appear that I or other realist commentators have made up the numbers$$. The money MYX have spent on S&M for the product is based on the totally unrealistic expectations they originally had and didn't get anywhere near. That's the company forecast, which is what us investors are reciting.

In regards to you telling me to get out of the stock - that's a few times I've seen you suggest that to people commenting on the stock more balanced, and better informed than yourself. Perhaps rather than being so one sided in your approach to commenting on MYX you should actually read and reflect; because a lot of what is being commented on is directly related to information that is freely available in the company releases, or via discussion forums which deal with peer reviewing MYX (and prevously TxD's) products.

Good luck with your investing.